ScholarIQanswers from OpenAlex

Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy

PaperCitations, authors & open-access status

Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy have?

ScholarIQcitation count

Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy has 55 citations in the OpenAlex counts ScholarIQ stores.

When was Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy published?

ScholarIQyear

Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy has 2025 year in the ScholarIQ index.

What is the open-access status of Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy?

ScholarIQoa status

Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy has gold oa status in the ScholarIQ index.

What is the DOI of Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy?

ScholarIQdoi

The DOI for Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy is on the source record.

What is the PMID of Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy?

ScholarIQpmid

The PMID for Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy is on the source record.

What is the OpenAlex record for Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy?

ScholarIQopenalex

The OpenAlex for Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial